Trigger mechanisms in insulin resistance and diabetes mellitus development

Abstract

Type 2 diabetes mellitus characterized by chronic hyperglycaemia is caused by insulin resistance and β-cell dysfunction. Glycogen accumulation, due to impaired metabolism, contributes to this “glucotoxicity” via dysregulated biochemical pathways promoting β-cell dysfunction. Thus, long-term exposition of insulin-secreted cells or isolated islets together with increased free fatty acids (FFA) and glucose levels can cause insulin-induced glucose secretion depression, damage to insulin gene expression and apoptotic death of cells. It is known that, the main regulator of pancreatic β-cells functioning and regulator of insulin gene expression, synthesis and secretion of insulin is glucose. Glucose enters cells and progressively metabolizes, in particular, to pyruvate in a cycle of tricarboxylic acids, subjected to oxidative phosphorylation, during which formed adenosine triphosphate and reactive oxygen radicals (ROS). Although, when more glucose enters the cell, there are other ways in which extra glucose can be transferred to reserve and of the glucose molecules can form ROS. The release of excessive amounts of FFA leads to lipotoxicity, as lipids and metabolites produce ROS in the endoplasmic reticulum and mitochondria. This affects both adipose and non-fat tissue, making up its pathophysiology in many organs. This overview demonstrates that the insulin gene is expressed in pancreatic β-cells. Glucose is the main physiological regulator of insulin gene expression. It controls the effect of transcription factors, insulin mRNA stability, and transcription rate. Glucolipotoxicity mechanisms affect the transcription factors MafA and PDX-1. Important is the β-cells damaging, which is connected with the oxidative stress and the synthesis of ceramides.

Keywords

Diabetes mellitus / insulin resistance / glucotoxicity / lipotoxicity

References

[1] Hall E,Volkov P,Mulder H.The effects of high glucose exposure on global gene expression and DNA methylation in human pancreatic islets..Mol Cell Endocrinol2018;472:57-67

[2] Bensellam M,Laybutt DR.Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.J Endocrinol2018;236:R109-43

[3] Robertson RP,Tanaka Y.Le Roith D,Olefsky JM.Glucose toxicity of the β-cell: cellular and molecular mechanisms. In: Diabetes mellitus. A fundamental and clinical text. 2nd ed..2000;PhiladelphiaLippincott Williams & Wilkins125-32

[4] Staiger H,Fritsche A.Pathomechanisms of type 2 diabetes genes..Endocr Rev2009;30:557-85

[5] Choe SS,Lee JW,Chung JJ.Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic β-cells..Diabetes2007;56:1534-43

[6] Juntilla M,Birnbaum MJ,Koretzky GA.Akt1 and Akt2 are required for alphabetathymocyte survival and differentiation..ProcNatlAcadSci U S A2007;104:12105-10 PMCID:PMC1924580

[7] Huang JP,Deng JY.Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats..J Biomed Sci2009;16:77 PMCID:PMC2740847

[8] Ide T,Yahagi N,Nakakuki M.SREBPs suppress IRS-2-mediated insulin signalling in the liver..Na Cell Biol2004;6:351-7

[9] Pettinelli P,Araya J,Araya AV.Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion..BiochimBiophysActa2009;1792:1080-6

[10] Huo M,Zhang DJ,Wu J.Role of increased activity of carbohydrate response element binding protein in excessive lipid accumulation in the liver of type 2 diabetic db/db mouse..Beijing Da Xue Xue Bao Yi Xue Bao2009;41:307-12(in Chinese)

[11] Poitout V.Glucolipotoxicity: fuel excess and β-cell dysfunction..Endocr Rev2007;29:351-66 PMCID:PMC2528858

[12] Ametov AS,Tselikovskaya AL.Obesity and cardiovascular diseases..Therapeutic Archive2001;73:66-9(in Russian)

[13] Kaneto H,Shiraiwa T,Kato K.Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells..Cur Med Chem2007;14:1745-52

[14] Nishimura W,Sharma A.Expression of MafA in pancreatic progenitors is detrimental for pancreatic development..Dev Biol2009;333:108-20 PMCID:PMC2737322

[15] Artner I,Guo M,Stein R.MafA is a dedicated activator of the insulin gene in vivo..J. Endocrinol2008;198:271-9 PMCID:PMC3787904

[16] Unger RH.The physiology of cellular liporegulation..Annu Rev Physiol2003;65:333-47

[17] Prentki M,El-Assaad W.Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes..Diabetes2002;51:S405-13

[18] Ashcroft FM,Clark A.Is type 2 diabetes a glycogen storage disease of pancreatic β cells?.Cell Metab2017;26:17-23 PMCID:PMC5890904

[19] Pelikánova T.Treatment of diabetes in metabolic syndrome..Vnitr Lek2009;55:637-45

[20] Schatz H.2008--The year of the big studies about the therapy of type-2-diabetes. ACCORD, ADVANCE, VADT, and the UKPDS 10-year follow-up data..MMW Fortschr Med2009;151:42-3

[21] Burkhardt BR,Young RA.PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter..Biochim Biophys Acta2008;1779:645-51 PMCID:PMC2574553

[22] Stanojevic V,Thomas MK.Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300..Endocrinology2004;145:2918-28

[23] Gao Y,Hart GW.The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 ß-cells..Arch Biochem Biophys2003;415:155-63

[24] Kishi A,Nishio Y,Kashiwagi A.Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation..Am J Physiol Endocrinol Metab2003;284:E830-40

[25] da Silva Xavier G,Ainscow EK.Regulation of gene expression by glucose in pancreatic ß-cells (MIN6) via insulin secretion and activation of phosphatidylinositol 3’-kinase..J Biol Chem2000;275:36269-77

[26] Khoo S,Xia Y,German MS.Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic ß cells..J Bio Chem2003;278:32969-77

[27] Zangen DH,Lee CH,Miller CP.Reduced insulin, GLUT2, and IDX-1 in ß-cells after partial pancreatectomy..Diabetes1997;46:258-64

[28] Leibowitz G,Apelqvist A,Gross DJ.IPF1/PDX1 deficiency and ß-cell dysfunction in Psammomysobesus, an animal with type 2 diabetes..Diabetes2001;50:1799-806

[29] Tanaka Y,Tran PO,Robertson RP.Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants..Proc Natl Acad Sci U S A1999;96:10857-62 PMCID:PMC17973

[30] Tajiri Y,Grill V.Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits β-cell function..Endocrinology1997;138:273-80

[31] Green K,Murphy MP.Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes..Diabetes2004;53:S110-8

[32] Gopaul NK,Mallet AI,Wolff SP.Plasma 8-epi-PGF2 levels are elevated in individuals with non-insulin dependent diabetes mellitus..FEBS Lett1995;368:225-9

[33] Yoshida K,Tagami S,Urata Y.Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux..Diabetologia1995;38:201-10

[34] Chaurasia B.Ceramides - lipotoxic inducers of metabolic disorders: (Trends in Endocrinology and Metabolism 26, 538-550; 2015)..Trends Endocrinol Metab2018;29:66-7

[35] Hagman DK,Parazzoli SD.Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans..J Biol Chem2005;280:32413-8 PMCID:PMC1361267

[36] Briaud I,Kelpe CL,Poitout V.Lipotoxicity of the pancreatic ß-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids..Diabetes2001;50:315-21 PMCID:PMC3547289

[37] Gwiazda KS,Lin Y.Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells..Am J Physiol Endocrinol Metab2009;296:E690-701

[38] Widenmaier SB,Kim SJ,McIntosh CH.Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide..J Biol Chem2009;284:30372-82 PMCID:PMC2781592

[39] Kaneto H,Shiraiwa T,Kato K.Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells..Curr Med Chem2007;14:1745-52

[40] Vallerie SN,Fucho R.A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity..PLoS One2008;3:e3151 PMCID:PMC2528001

[41] Kawamori D,Nakatani Y,Matsuhisa M.The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation..J Biol Chem2006;281:1091-8

[42] Weber C,Münk A,Van Veldhoven PP.Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice..J Immunol2009;183:4292-301

[43] Zhou YP.Long-term exposure to fatty acids and ketones inhibits β-cell functions in human pancreatic islets of Langerhans..J ClinEndocrinol. Metab1995;80:1584-90

[44] Mason TM,Tchipashvili V,Gupta N.Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats..Diabetes1999;48:524-30

[45] Paolisso G,Amato L,D’Amore A.Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects..Diabetologia1995;38:1295-9

[46] Liu YQ,Leahy JL.Fatty-acid induced β-cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content..J Clin Invest1998;101:1870-5 PMCID:PMC508772

[47] Magnan C,Berthault MF,Vincent M.Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose..J Clin Invest1999;103:413-9 PMCID:PMC407894

[48] Zhang CY,Perret P,Peroni O.Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β-cell dysfunction, and type 2 diabetes..Cell2001;105:745-55

[49] Joseph JW,Zhang CY,Lowell BB.Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet..Diabetes2002;51:3211-9

[50] Lameloise N,Prentki M.Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?.Diabetes2001;50:803-9

[51] Medvedev AV,Bai X,Floering LM.Regulation of the uncoupling protein-2 gene in INS-1 β-cells by oleic acid..J BiolChem2002;277:42639-44

[52] Medvedev AV,Raimbault S,Collins S.Transcriptional regulation of the mouse uncoupling protein-2 gene. Double E-box motif is required for peroxisome proliferator-activated receptor- -dependent activation..J BiolChem2001;276:10817-23

[53] Roche E,Witters LA,Thumelin S.Long-term exposure of β-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, andlipogenic gene expression..Diabetes1998;47:1086-94

[54] Ruderman N.AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome..Nat Rev Drug Discov2004;3:340-51

[55] Wang X,Li G,Gu Y.Palmitate activates AMP-activated protein kinase and regulates insulin secretion from β cells..Biochem Biophys Res Commun2007;352:463-8

[56] Brøns C.Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes..J Physiol2009;587:3977-8 PMCID:PMC2756432

[57] Dalle S.Diabetes: what are the key targets and the objectives? Preserving and protecting a functional pancreatic beta cell mass..Biol Aujourdhui2017;211:165-8(in French)